M&A breaks the $200B barrier; GSK hands over $5M milestone;

@FierceBiotech: The JP Morgan mood: Damn the valuations and full speed ahead in 2015. Article | Follow @FierceBiotech

@JohnCFierce: Enanta plots a future in NASH, chasing another blockbuster. Story | Follow @JohnCFierce

> M&A accounted for more than $200 billion in deals last year, reports EvaluatePharma. But the most surprising part of that is that the industry hit that big number through a slate of smaller deals, without any megamergers to swell the figures. Story

> GlaxoSmithKline ($GSK) handed over a $5 million milestone to OncoMed Pharmaceuticals after the biotech enrolled the first biomarker-selected patient in its anti-Notch1 antibody (OMP-52M51) Phase Ia solid tumor clinical trial. Release

Medical Device News

@FierceMedDev: LabCorp-backed GeneCentric raising $20M Series B to build portfolio of molecular diagnostic tests. More | Follow @FierceMedDev

@VarunSaxena2: Tekmira stock soars on acquisition of OnCore to strengthen hep B pipeline. Story | Follow @VarunSaxena2

@EmilyWFierce: Bard loses bid to delay vaginal mesh trial proceedings. Article | Follow @EmilyWFierce

> What's next for next-gen sequencing? Everything. Editor's corner

> At JP Morgan, Stryker CEO embraces sales reps, dismisses Smith & Nephew plan to eliminate them. More

Pharma News

@FiercePharma: Could Zambian bats hold the key to curing Ebola? More | Follow @FiercePharma

@CarlyHFierce: Pfizer developing cholesterol-fighting vaccine as part of PCSK9 'franchise.' News | Follow @CarlyHFierce

> Boehringer weighs $2B-plus sale of U.S. generic biz as part of slimdown regimen. Report

> World's first inactivated Sabin polio vaccine approved by China FDA. More

> Armed with Pegasus win, AstraZeneca targets another sales boost for Brilinta. Article

Vaccines News

> Late-stage trials for Glaxo, Merck Ebola jabs could begin this month in West Africa. Story

> WHO approves MenAfriVac for routine infant immunization in sub-Saharan Africa. Report

> J&J partners with AC Immune on anti-tau Alzheimer's vaccine. More

> Pfizer developing cholesterol-fighting vaccine as part of PCSK9 'franchise.' Article

> China approves world's first inactivated Sabin polio vaccine. Item

Pharma Manufacturing News

> Hospira to close Clayton, NC, production plant. Story

> Indian state hires FDA's online education provider to train inspectors. Article

> FDA links saline supply chain mixup to patient death. News

> Piramal lines up $40M investment in equipment and technology. Item

> New FDA quality office to grade manufacturing operations. More

> Boehringer mulls sale of generic plant as stateside shakeup continues. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.